By Mariam Sunny Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy slowed disease ...
A commercial partnership between Topcon Healthcare and RemoniHealth is integrating the latter’s home-based ocular disease ...
“Weight-loss methods, whether with pharmacotherapy or surgery, have to be mindful to avoid inducing these complications,” ...
A string of clinical and regulatory milestones in the December quarter highlighted growing momentum for ASX health stocks ...
[28 January 2026]: Roche Diagnostics Middle East presented a landmark launch event revealing Accu-Chek SmartGuide, a ...
News-Medical.Net on MSN
Minimally invasive biopsy enables real-time tracking of amyloid disease progression
Transthyretin amyloidosis (ATTR) is a rare, progressive and highly aggressive degenerative disease. It is caused by the ...
Fast-RSOM skin scan identifies early cardiovascular risk by imaging tiny blood vessels and functional changes before symptoms ...
It's "really bad." ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a highly prevalent chronic liver condition globally, with its management spanning ...
Glaucoma diagnostics and imaging technology represent a rapidly evolving area at the intersection of clinical ophthalmology, biomedical engineering, and ...
About BioNexus Gene Lab Corp. BioNexus Gene Lab Corp. (NASDAQ: BGLC) is a biotechnology company advancing precision diagnostics and gene-based technologies. The Company is building a platform spanning ...
Jan 26 (Reuters) - Sarepta Therapeutics' gene therapy for a muscle‑wasting disorder slowed disease progression and showed sustained benefit in patients' ability to control and coordinate movement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results